Alexis Balvair is a distinguished leader in healthcare administration with extensive experience navigating the complex legal landscapes of payer-provider relations. Throughout a career spent managing large-scale health systems and advising on insurance law, she has become a primary voice for hospitals facing aggressive reimbursement tactics. Her deep understanding of the financial and regulatory challenges facing modern medical facilities provides a rare window into the high-stakes legal battles currently shaping the future of American healthcare. This conversation explores the rising tide of litigation, covering everything from controversial network penalty policies and the nuances of out-of-network emergency billing to the administrative fallout of downcoding and inpatient reclassification.
Some payers now reduce hospital reimbursements by 10% when patients are treated by out-of-network physicians at in-network facilities. How does this penalty impact a hospital’s ability to cover its overhead, and what specific legal arguments are most effective when challenging these “network penalty policies” in court?
The financial strain of a 10% reduction is devastating because it targets the core revenue stream of hospitals that have already negotiated in good faith to stay in-network. This penalty essentially punishes a facility for staffing choices it may not fully control, draining resources that are vital for maintaining 24/7 emergency readiness and specialized medical equipment. When we take these cases to court, our most effective legal argument is that these policies are a flagrant attempt to bypass state reimbursement requirements and ethically compromise the hospital’s negotiating position. We argue that the payer is unilaterally altering the terms of a contract to boost their own profits, which ultimately threatens the stability of care for millions of residents who expect their insurance to honor their choice of doctor.
When contract negotiations fail and a health system goes out-of-network, disputes often arise over “usual and customary” rates for emergency services. What specific metrics should providers use to establish fair market reimbursement, and what are the operational risks of seeking interest on underpaid claims through litigation?
When we find ourselves in the “out-of-network” wilderness, we rely on established market-based reimbursement levels rather than the arbitrary, discounted rate schedules payers try to impose. It is critical to use billed charges and regional data for similar emergency services to prove that the reimbursement being offered is below “usual and customary” standards. However, seeking the 12% annual interest often allowed under state law is a high-risk operational move because it requires the health system to carry millions in unpaid accounts receivable for years. This creates a massive cash flow gap that can delay vital facility upgrades or staffing expansions, making it a necessary but painful path to take when a dominant payer refuses to pay fairly.
New policies are reclassifying some inpatient stays as lower-paying “observation-level” visits if the patient is discharged within four midnights. How does this downcoding affect a provider’s administrative workload during appeals, and what step-by-step changes should clinical teams make to ensure compliance with the federal two-midnight rule?
The shift toward “observation-level” billing for stays between one and four midnights is an administrative nightmare that forces our staff to spend countless hours fighting for every dollar through a grueling appeals process. This downcoding ignores the clinical judgment of physicians who have formally admitted a patient, effectively creating a new payment tier that was never part of the original contract negotiations. To combat this, clinical teams must meticulously document the physician’s expectation at the time of admission, specifically showing why the patient required hospital-level care for at least two midnights. We are essentially retraining our medical staff to be as skilled in regulatory documentation as they are in bedside care to ensure we meet the federal standards that Medicare Advantage plans are legally required to follow.
Payers often argue that payment reductions are necessary to prevent billing that significantly exceeds Medicare rates, while providers view these tactics as unilateral contract breaches. How can health systems better prepare for these high-stakes negotiations, and what data points are essential for proving the value of in-network care?
Health systems must go into negotiations armed with data that proves the massive cost of maintaining a 24-hour safety net, which Medicare rates often fail to cover. We need to demonstrate that the payer’s attempts to “incentivize” lower billing through penalties are actually breaches of contract that undermine the very fabric of local healthcare delivery. Essential data points include the severity of the cases we handle and the specific outcomes that justify our rates compared to the cut-rate options payers prefer. By showing the court that these “cost-saving” policies are actually unethical tactics designed to force hospitals into accepting sub-market rates, we can better protect the financial integrity of the institution.
What is your forecast for provider-payer litigation trends?
I forecast a significant surge in litigation as health systems move from defensive posturing to aggressive legal action against what we see as policy overreach. We are seeing a shift where providers are no longer willing to absorb the costs of unilateral changes like the two-midnight rule variations or network penalties, leading to more class-action style lawsuits from state hospital associations. As insurers continue to prioritize profit margins by downcoding inpatient stays and applying unlawful discounts, the courtroom will become the primary arena for defining the “usual and customary” value of healthcare. Ultimately, this trend will likely force a federal or state-level legislative reckoning to clarify the boundaries of how much control a private insurer can exert over a physician’s clinical decisions.
